» Articles » PMID: 31599856

The Role of Surgery in High-risk Neuroblastoma

Overview
Specialty Pediatrics
Date 2019 Oct 11
PMID 31599856
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Although intensive multimodal treatment has improved outcomes for patients with high-risk neuroblastoma, the specific role of primary tumor resection remains controversial. Many studies have been designed to determine whether the extent of surgical resection impacts survival; however, these reports have demonstrated conflicting results. There is also ongoing debate regarding the timing of primary tumor resection, with subtle differences in the approach between the large pediatric oncology cooperative consortia. Most of the published literature to date has been approached from a surgical viewpoint. Although most evidence supports surgery as part of the local control approach for high-risk neuroblastoma, recommendations for timing and extent of surgical resection are not consistent. This review summarizes our current understanding from the perspectives of both the pediatric oncologist and pediatric surgeons and discusses how the objectives of neuroblastoma primary surgical resection are different from that of other malignancies. Furthermore, this commentary will address how retrospective surgical outcome data may be interpreted in the setting of modern era high-risk neuroblastoma treatment.

Citing Articles

Migration, invasion, and metastasis are mediated by in neuroblastoma.

Jacobson J, Qiao J, Cochran E, McCreery S, Chung D Front Oncol. 2024; 14:1336031.

PMID: 38884093 PMC: 11176429. DOI: 10.3389/fonc.2024.1336031.


Clinical characteristics and prognoses in pediatric neuroblastoma with bone or liver metastasis: data from the SEER 2010-2019.

Zhao X, Xu Z, Feng X BMC Pediatr. 2024; 24(1):162.

PMID: 38454422 PMC: 10921780. DOI: 10.1186/s12887-024-04570-z.


Perioperative complication incidence and risk factors for retroperitoneal neuroblastoma in children: analysis of 571 patients.

He M, Cai J, Wu X, Tang Y, Wang J, Mao J World J Pediatr. 2023; 20(3):250-258.

PMID: 38070095 PMC: 10957663. DOI: 10.1007/s12519-023-00773-z.


Treatment of High-Risk Neuroblastoma.

Krystal J, Foster J Children (Basel). 2023; 10(8).

PMID: 37628301 PMC: 10453838. DOI: 10.3390/children10081302.


Beyond image defined risk factors (IDRFs): a delphi survey highlighting definition of the surgical complexity index (SCI) in neuroblastoma.

Avanzini S, DallIgna P, Bjornland K, Braungart S, Cross K, Flores P Pediatr Surg Int. 2023; 39(1):191.

PMID: 37140693 DOI: 10.1007/s00383-023-05477-z.